Dr. Bedlack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
932 Morreene Rd
Durham, NC 27705Phone+1 919-668-7600- Is this information wrong?
Education & Training
- Duke University HospitalResidency, Neurology, 1996 - 1999
- Duke University HospitalInternship, Internal Medicine, 1995 - 1996
- Uconn School Of MedicineClass of 1995
Certifications & Licensure
- NC State Medical License 1995 - 2024
- VA State Medical License 2000 - 2002
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease Start of enrollment: 2006 May 01
- A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients Start of enrollment: 2011 Sep 01
- Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- ALSUntangled #72: Insulin.Andrew Brown, Carmel Armon, Paul Barkhaus, Morgan Beauchamp, Tulio Bertorini, Mark Bromberg, Javier Mascias Cadavid, Gregory T Carter, Jesse Crayle, Eva L Feldman, Ter...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 May 1
- ALSUntangled #75: Portable neuromodulation stimulator therapy.Laurel Officer, Carmel Armon, Paul Barkhaus, Morgan Beauchamp, Michael Benatar, Tulio Bertorini, Robert Bowser, Mark Bromberg, Andrew Brown, Olimpia Mihaela Carbunar, ...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 Apr 26
- Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis.Xiaoyan Li, Richard Bedlack> ;Expert Opinion on Emerging Drugs. 2024 Mar 22
- Join now to see all
Journal Articles
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisBrian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
Press Mentions
- NIH to Fund Unproven ALS Drugs Under Patient-Backed LawOctober 1st, 2022
- NIH to Fund Unproven ALS Drugs Under Patient-Backed LawOctober 1st, 2022
- NIH to Fund Unproven ALS Drugs Under Patient-Backed LawOctober 1st, 2022
- Join now to see all
Hospital Affiliations
- Duke University HospitalDurham, North Carolina
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: